raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:500478

Squamous cell carcinoma of the oropharynx

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Elderly
Status
active

A rare head and neck tumor characterized by a malignant epithelial neoplasm with evidence of squamous differentiation, which may arise in association with high-risk HPV in a subset of cases. HPV-positive tumors have a strong predilection for the base of tongue and the palatine tonsils and typically present at an advanced clinical stage with cervical lymphadenopathy. They are associated with significantly better prognosis than HPV-negative tumors, which more commonly involve the soft palate, manifest as sore throat and difficulty in swallowing or a neck mass, and occur in older patients. Smoking and alcohol consumption are important risk factors.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSquamous cell carcinoma of the oropharynx
frCarcinome épidermoïde de l'oropharynxCarcinome épidermoïde oropharyngé
dePlattenepithelkarzinom des Oropharynx
esCarcinoma de células escamosas de la orofaringe
itCarcinoma a cellule squamose dell'orofaringe
nlPlaveiselcelcarcinoom van orofarynx
ptCarcinoma de células escamosas da orofaringe
plRak płaskonabłonkowy gardła środkowego
csDlaždicobuněčný karcinom oropharyngu
ukПлоскоклітинний рак ротоглотки
zh口咽鳞状细胞癌
trOrofarinksin skuamöz hücreli karsinomu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM275355NTBTvalidated
ICD-10C10.8NTBTattributedvalidated
ICD-112B6A.0Especificvalidated
MONDO0044704Evalidated
UMLSC0280313Evalidated
MedDRA10031112Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ING1Disease-causing somatic mutation(s) inAssessedHGNC:6062ENSG0000015348760156613q34inhibitor of growth family member 110866301[PMID]
PTENDisease-causing somatic mutation(s) inAssessedHGNC:9588ENSG0000017186260172810q23.31phosphatase and tensin homolog11801303[PMID]
TNFRSF10BMajor susceptibility factor inAssessedHGNC:11905ENSG000001208896036128p21.3TNF receptor superfamily member 10b9721831[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 100 0003.12 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]_28687376[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card